| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/08/2004 | US20040132670 Method of production of an isomaltulose-containing enteral nutrient |
| 07/08/2004 | US20040132669 Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
| 07/08/2004 | US20040132644 Composition and method for treating diabetes |
| 07/08/2004 | US20040132163 Biological materials and uses thereof |
| 07/08/2004 | US20040132139 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/08/2004 | US20040132093 Comprises cytokine receptor fusion protein for use in indentifying modulators for treatment of bone disorders |
| 07/08/2004 | US20040132038 Membrane protein for use as diagnostic tool in the detection and prevention of cell proliferative, cardiovascular, skin, nervous system, respiratory and metabolic disorders |
| 07/08/2004 | US20040132020 Novel enzyme gene and its expression product |
| 07/08/2004 | US20040131657 Mixture of glucans and sterols |
| 07/08/2004 | US20040131585 Identification and use og human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 07/08/2004 | US20040131583 Biocompatible polymers, process for their preparation and compositions containing them |
| 07/08/2004 | DE10258008A1 Neue heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New heterocyclic Fluorglycosidderivate, pharmaceutical compositions containing them and their use |
| 07/08/2004 | DE10142662B4 Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel Derivatives of C2-substituted indan-1-ol-systems and their use as medicaments |
| 07/08/2004 | CA2511144A1 Ghrelin receptor inverse agonist for regulation of feeding behaviours |
| 07/08/2004 | CA2510458A1 Compositions of cholesteryl ester transfer protein inhibitors and hmg-coa reductase inhibitors |
| 07/08/2004 | CA2508621A1 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/08/2004 | CA2506627A1 Use of .alpha.-phenylthiocarboxylic and .alpha.-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity |
| 07/08/2004 | CA2505604A1 Microsomal triglyceride transfer protein inhibitors |
| 07/07/2004 | EP1435244A1 Drugs ameliorating hypo-hdl cholesterolemia |
| 07/07/2004 | EP1435240A2 Solid oral dosage form comprising a combination of methformin and glibenclamide |
| 07/07/2004 | EP1435235A1 Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 07/07/2004 | EP1434886A2 Mid 241 receptor, a novel g-protein coupled receptor |
| 07/07/2004 | EP1434885A2 21132, a human g-protein coupled receptor family member and uses therefor |
| 07/07/2004 | EP1434860A2 Enzymes |
| 07/07/2004 | EP1434798A2 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
| 07/07/2004 | EP1434796A2 Secreted proteins |
| 07/07/2004 | EP1434792A2 Peptidyl ketones as inhibitors of dpiv |
| 07/07/2004 | EP1434791A2 Specific binding agents of human angiopoietin-2 |
| 07/07/2004 | EP1434790A1 Calcium-influx inhibitory factor and method of isolation thereof |
| 07/07/2004 | EP1434788A2 Proteins associated with cell growth, differentiation, and death |
| 07/07/2004 | EP1434786A1 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 07/07/2004 | EP1434785A2 Protein modification and maintenance molecules |
| 07/07/2004 | EP1434775A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 07/07/2004 | EP1434774A1 3-(4-substituted heterocyclyl)-pyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 07/07/2004 | EP1434773A2 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 07/07/2004 | EP1434772A1 Compounds and methods |
| 07/07/2004 | EP1434769A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 07/07/2004 | EP1434765A1 Substituted piperidines with selective binding to histamine h3-receptor |
| 07/07/2004 | EP1434763A2 Beta-lactamyl vasopressin v1a antagonists |
| 07/07/2004 | EP1434624A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 07/07/2004 | EP1434601A2 Liposome-encapsulated insulin formulations |
| 07/07/2004 | EP1434599A1 Human 3 relaxin |
| 07/07/2004 | EP1434598A2 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| 07/07/2004 | EP1434597A1 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 07/07/2004 | EP1434594A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 07/07/2004 | EP1434583A1 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 07/07/2004 | EP1434581A1 3- hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7,8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitors |
| 07/07/2004 | EP1434578A1 Arylsulphonyl-substituted tetrahydro- and hexahydro-carbazoles as 5-ht-6 receptor ligands |
| 07/07/2004 | EP1434575A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites |
| 07/07/2004 | EP1434572A2 Galenic microparticulate oral formulation for delayed and controlled release of pharmaceutical active principles |
| 07/07/2004 | EP1434567A1 Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid |
| 07/07/2004 | EP1401431A4 Human growth hormone antagonists |
| 07/07/2004 | EP1377280A4 Bulking agents as satiety agents |
| 07/07/2004 | EP1242404B1 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 07/07/2004 | EP1237864B1 Process for the preparation of amorphous atorvastatin |
| 07/07/2004 | EP1235827B1 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 07/07/2004 | EP1230222B1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 07/07/2004 | EP1222251A4 Ex vivo generation of functional osteoclasts from bone marrow in a three-dimensional bioreactor |
| 07/07/2004 | EP1196195A4 Nasogastric enteral formulations |
| 07/07/2004 | EP1087971B1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 07/07/2004 | CN1511193A Method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby |
| 07/07/2004 | CN1511189A Process for preparing vegetable oil fractions rich in non-tocolic high-melting, unsaponifiable matter |
| 07/07/2004 | CN1511157A Novel pyrrole derivatives as pharmaceutical agents |
| 07/07/2004 | CN1511154A Quinuclidines-substituted-multi-cycli-heteroaryls for treatment of disease |
| 07/07/2004 | CN1511149A 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry |
| 07/07/2004 | CN1511137A Hydro phobic polyamine analogs and methods for their use |
| 07/07/2004 | CN1511040A Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 07/07/2004 | CN1511039A Method for lowering serum glucose |
| 07/07/2004 | CN1511038A Combination therepy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 07/07/2004 | CN1509761A Cordyceps Eightzhen capsules |
| 07/07/2004 | CN1509750A Papaya activated fiber biological preparation |
| 07/07/2004 | CN1509738A Composition for adjusting blood fat and preparing method thereof |
| 07/07/2004 | CN1509723A Compound phenformin |
| 07/07/2004 | CN1509713A Indole derivative use as 5HT1 antagonist agent |
| 07/07/2004 | CN1509711A Fenfibrate masticatory and its preparation |
| 07/07/2004 | CN1509619A Red rooted salvia |
| 07/07/2004 | CN1156492C Somatostatin peptides |
| 07/07/2004 | CN1156480C Water soluble SDZ-RAD esters, its preparation method, use and composition thereof |
| 07/07/2004 | CN1156473C Hydrochloride of fused-heterocycle compound |
| 07/07/2004 | CN1156471C 5-phridyl-1,3-azole compounds, process for producing the same and use thereof |
| 07/07/2004 | CN1156454C Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 07/07/2004 | CN1156452C Compound as anti-inflammatory agent |
| 07/07/2004 | CN1156296C Oral liquid containing calcium |
| 07/07/2004 | CN1156282C 活性山羊血粉胶囊 Activity goat blood meal capsule |
| 07/07/2004 | CN1156277C Rapidlly soluble drug composition |
| 07/07/2004 | CN1156276C New use of theaflavin |
| 07/06/2004 | US6759546 Reducing serum glucose and serum triglyceride levels in diabetic mammals without the undesirable property of reducing serum thyroxine levels |
| 07/06/2004 | US6759535 A 3-amide-methyl- or 3-urea-isoquinoline derivatives, enzyme inhibitor of protein kinase, for treating cell proliferation, cell death, inflammatory diseases, autoimmune diseases, bone disorders, infectious diseases, viral diseases |
| 07/06/2004 | US6759534 Reacting benzofuran derivative with organolithium compound in presence of sulfur source; reacting with dichloropyridazine derivative, reacting with alkaline alkoxide in alkanol; reacting with mineral acid, oxidation |
| 07/06/2004 | US6759437 Comprehensive pharmacologic therapy for treatment of obesity including cysteine |
| 07/06/2004 | US6759430 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/06/2004 | US6759424 Imidazolidine derivatives, their preparation, their use, and pharmaceutical preparations comprising them |
| 07/06/2004 | US6759422 Administering benzothiazole compound for therapy, prophylaxis of disease |
| 07/06/2004 | US6759421 Indoline compounds, a process for their preparation and pharmaceutical compositions containing them |
| 07/06/2004 | US6759415 Affinity with subtypes of somatostatin receptors |
| 07/06/2004 | US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 07/06/2004 | US6759405 Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| 07/06/2004 | US6759396 Compositions based on a synergistic mixture of at least one VDR ligand and a retinoid |
| 07/06/2004 | US6759387 Delivery enhancing transporter that has sufficient guanidino or amidino sidechain moieties to enhance delivery of a compound conjugated to the reagent across one or more layers of the tissue |
| 07/06/2004 | US6759208 Prevention, therapy disease; forming tritiated water; calibration |